[The interauricular laser therapy of rheumatoid arthritis].
Investigations have proved the ability of interauricular low-intensity infrared laser therapy (0.89 nm, 7.6 J/cm) to produce anti-inflammatory, immunomodulating action in patients with rheumatoid arthritis. The method has selective, pathogenetically directed immunomodulating effect the mechanism of which is similar to that of basic antirheumatic drugs and of intravenous laser radiation of blood. This laser therapy can be used as an alternative to intravenous blood radiation being superior as a noninvasive method. Interauricular laser therapy can potentiate the effects of nonsteroid anti-inflammatory drugs, cytostatics and diminish their side effects.
Sidorov
V D
VD
Mamiliaeva
D R
DR
Gontar'
E V
EV
Reformatskaia
S Iu
SIu
D000917:Antibody Formation / Q000528:radiation effects; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000276:immunology / Q000532:radiotherapy* / Q000534:rehabilitation; D015551:Autoimmunity / Q000528:radiation effects; D003131:Combined Modality Therapy; D004431:Ear, External; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000528:radiation effects; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged
Interaurikuliarnaia lazernaia terapiia revmatoidnogo artrita.